无痛分娩对产程及妊娠结局影响的临床观察及效果分析

目的分析无痛分娩对产程及妊娠结局影响的临床观察及效果。方法随机选取2013年7月至2015年6月我院收治的260例产妇病例作为研究对象,采用回顾分析法,将其分为观察组与对照组各130例,对照组主要采用常规分娩方式,观察组主要采用无痛分娩方式,观察两组患者的产程、分娩方式、产后出血等临床效果。结果对照组的产后出血量(183±26)m L,观察组产后出血量(153±21)m L,两组患者的比较差异具有统计学意义(P<0.05);在产程中,观察组的第一产程与第二产程要比对照组短,两组患者的比较差异具有统计学意义(P<0.05)。在分娩方式中,对照组顺产37例、产钳助产13例、剖宫产80例,观察组顺产32例、产钳助产10例、剖宫产88例,两组患者之间的比较无差异(P>0.05)。结论无痛分娩可以有效缓解产妇在分娩中的疼痛,降低患者的压力,提高生产安全性,还可以有效的减少产程时间以及顺产的风险,有利于产妇产后恢复,值得推广使用。

腹针治疗单纯性肥胖症70例临床观察

目的 :观察腹针治疗单纯性肥胖症的疗效。方法 :对 70例单纯性肥胖症患者运用腹针治疗。结果与治疗 :腹针治疗后有一定的疗效 ,腹针能达到调节内分泌与神经系统及新陈代谢等。

肺癌脑转移的放射治疗19例临床观察

分析 19例肺癌脑转移患者 ,1例脑干转移者行单纯局部60 Coγ线放疗 ,DT :5 5Gy。其余 18例 :6例60 Coγ线照射 ,12例 6MVX线照射全脑照射剂量达 4 0Gy后 ,缩野对肿瘤局部加量 15～ 2 0Gy。结果放疗结束时 12例头痛、恶心、呕吐患者症状均消失 ,6例肢体活动受限及 1例吞咽困难者症状改善。生存期 5～ 18月 ,中位生存期 8.0月。认为放疗是治疗肺癌脑转移瘤安全。

中西医结合治疗妊娠合并哮喘30例的临床观察

目的:观察中西医结合治疗妊娠合并哮喘临床疗效。方法:把60例患者随机分为治疗组和对照组,治疗组西医吸氧、抗炎、缓解支气管痉挛、稀释痰液等治疗,中医健脾益气生津,化痰降逆平喘,清肺滋肾安胎为法,以自拟平喘安胎方辩证加减,同时配心理疏导及预防治疗;对照组予西医治疗。结果:χ2=22.35,P<0.005,两组有显著性差异。结论:西医治疗迅速控制该病症状,中医治疗增加疗效,减少该病复发,中西医结合治疗可提高疗效。

低平牙槽嵴下颌总义齿修复的临床观察

目的对低平牙槽嵴下颌总义齿修复的临床疗效进行观察。方法从2012年3月~2017年3月口腔科收治的低平牙槽嵴下颌总义齿严重吸收的患者中选取60例进行研究,均接受修复治疗,对其展开随访,观察修复效果。结果经统计,本组患者下颌总义齿修复的成功率为98.33%(59/60),对新义齿的适应时间为1~5个月,平均(3.28±0.54)个月。随访发现,患者的牙槽嵴吸收情况均为发生明显变化,义齿使用正常。结论在修复低平牙槽嵴下颌总义齿时需要综合考虑基托、舌运动、磨光面、牙颌面等多个因素,这样才能增强义齿的稳定性和固位力。

痰热清注射液治疗病毒性乙型肝炎疗效观察

目的:观察痰热清注射液治疗病毒性乙型肝炎疗效。方法:97例病毒性乙型肝炎患者随机分为2组,治疗组49例,给予痰热清20 ml加入250 ml液体中静滴,门冬氨酸钾镁10 ml及强力宁80 ml加入250ml液体中静滴,均为每日1次,连用3周;对照组48例,只给予门冬氨酸钾镁及强力宁,剂量疗程与治疗组相同。结果:治疗组肝功能TBIL、ALT改善程度与对照组比较,与治疗前比较均有显著性差异(P<0.01),两组疗效相比治疗组有效率91%,对照组有效率85%。结论:痰热清具有消炎利疸,恢复肝功能的功效。

森田疗法和内观疗法整合用于神经症的理论及实践

目的:探讨森田疗法和内观疗法整合应用于神经症的可能性。方法:本文详细阐述了森田疗法和内观疗法两种理论的独到之处和共通之处,创造性的提出森田疗法和内观疗法整合的理论基础,对其整合应用的互补优势做了论述;并将两者整合后应用于临床的观察做了描述。结果:内观疗法首先启动了患者的情感,正性情感启动下的森田式行为主动性提高;两者整合其情感-行为互补优势明显。结论:森田疗法和内观疗法的整合应用,更能促进患者的人格成长和完善,从实践上证明了两者整合应用于神经症的可行性。

四物汤加味治疗胞轮振跳30例观察

目的:观察四物汤随证加味治疗胞轮振跳的疗效。方法:采用治疗组30例36只服,四物汤为基础随证加味内服;对照组30例42只服,口服维生素B1、ATP片、葡萄糖酸钙片等。结果:治疗组和对照组经统计学分析,有显著性差异,治疗组优于对照组。结论:四物汤随证加味治疗胞轮振跳具有独特的疗效。

中西医结合治疗盆腔炎158例疗效观察

目的探讨中药盆腔炎方联合抗生素对盆腔炎的治疗作用。方法将237例病人分为A组(抗生素组)79例,B组(中西医结合组)158例。结果A组总有效率89.88%,B组总有效率97.47%,两组比较差异有统计学意义(P<0.05)。结论中西医结合疗法治疗盆腔炎优于单纯应用抗生素治疗。

Preparation and Preliminary Clinical Observation of Zipu Capsule

[Objective] To study the preparation of Zipu Capsule and its clinical effect on the treatment of chronic periodontitis. [Method] The extraction, concentration, drying and preparation process of the raw herbal materials for Zipu Capsule were selected out. And 60 cases of chronic periodontitis patients were randomly assigned to two groups and were treated with conventional therapy and nursing care, while the treatment group was added with taking the Zipu capsule, to compare the cura- tive effects of the two groups. [Result] Both of two groups showed decreases in gingival index （GO, periodontal pocket depth （PD） and attachment loss values （AL） after treatment, and those of the treatment group was significantly lower than those of the control group （P〈0.05）. The total curative effective rate of the treatment group was 91.17%, and 76.92% in the control group, and the differences between the two groups reached the significant level （P〈0.05）. [Conclusion] Zipu Capsule had definite therapeutic effect in treatment of chronic periodontitis and less adverse re- actions, which laid the foundation for the further development into drug products.

CLINICAL REPORT ON MULTI-CENTER RANDOMIZED CONTROLLED TRIAL OF TREATMENT OF MIGRAINE BY ELECTRO-ACUPUNCTURE AT QI■X■(丘墟GB40)

Objective To observe the therapeutic effect of electro acupuncture at QIǖXǖ（丘墟GB40） for treating migraine and provide clinical study for Acupoints Dictionary of People＇s Republic of China. Methods Multi-center （3 First-Class hospitals） study was adopted, and the involved 3 hospitals did clinical observation according to the requirements of the project. The methods are as follows. All cases were randomized into treatment group and control group according to their sequence. QIǖXǖ（丘墟GB40） was selected in treatment group, while Tiānshū （天枢 ST25） was selected in control group. Both groups were performed electro acupuncture, and syndromes indexes of migraine and 5-HT were observed before and after treatment. All data were analyzed by statistic software SPSS11.5. Results There was significant difference of VAS margin between two groups in each center and the combined center （u= -3. 362, P=0. 001 ）. There was significant difference of therapeutic effect of 4-week treatment between two groups in each clinical center and the combined center. The therapeutic effect of 3-month treatment between two groups in No. 1 and No. 3 hospitals, showed significant difference, the treatment group was better; while that of No. 2 hospital had no obvious difference. The therapeutic effect of 6-month treatment between two groups in each center and the combined center had significant difference, the treatment group was better. Conclusion The therapy of electro acupuncture at QIǖXǖ（丘墟GB40） is effective for migraine.

王烈教授的科学思维方法研究

王烈教授为吉林省中医药终身教授,国家中医药管理局确定的第一、二、三、四批全国老中医药专家学术经验继承工作指导教师,第二批全国优秀中医临床人才指导教师。从事中医儿科医疗、教学及科研工作五十余年,学验颇丰。从中医的学习观到临床诊治观,均蕴涵着科学的辨证创新的思维方法。

影响客观结构化临床考试因素的分析

自从Harden于1975年首次提出客观结构化临床考试(Obiective Structured Clinical Examination，简称OSCE)以来，越来越多的国外医学教育机构把OSCE用做一种临床能力的评价工具，自从1993年加拿大医学委员会把OSCE应用于医师执照考试以后。

中西医结合治疗荨麻疹56例

目的:观察中西医结合治疗荨麻疹的疗效。方法:56例患者采用中西医结合的方法治疗。结果:56例患者治愈率75%,有效率16%,总有效率95%。结论:中西医结合治疗荨麻疹效果确切。

Acupuncture Treatment of Chronic Superficial Gastritis by the Eight Methods of Intelligent Turtle

With the clinical manifestations and the point electric conduction volume as the indexes, the authors observed the immediate effects of the acupuncture treatment on chronic superficial gastritis with the points selected according to the date and time set by Ling Gui Ba Fa (灵龟八法 Eight Methods of Intelligent Turtle), which was compared with the effects in the control group treated with the points selected according to syndrome-differentiation. A higher symptom improvement rate (P<0.01) and a higher channel's balance-inverting rate were noticed in the former (P<0.01), indicating that Ling Gui Ba Fa can give a better therapeutic results.

Clinical Observation on the Method of Supplementing Qi,Clearing away Heat and Promoting Blood Circulation for Treating 53 Cases of Gastritis Related to Pyrolic Helicobacterium

According to the clinical experience of professor Shan Zhaowei (单兆伟), the author has successfully developed Qingyou Yangwei Capsule (清幽养胃胶囊capsules for eliminating pyrolic Helicobacterium and nourishing the stomach) for treating the gastritis. Clinical research has shown that the capsule has a good curative effect on chronic gastritis related to pyrolic Helicobacterium. Among the 53 cases in the treatment group, clinical observation showed cure in 6 cases, obvious effect in 18 cases, effect in 24 cases, no effect on 5 cases, with a total effective rate of 90.5%. Of the 50 cases in the control group, cure was found in 5 cases, obvious effect in 13 cases, effect in 20 cases, no effect in 12 cases, the total effective rate being 76%. The total effective rate in the treatment group was higher than that in the control group. The rate of eliminating pyrolic Helicobacterium in the treatment group was 66.04%, similar to that in the control group. In a follow-up visit 6 months later, the recurrence rate in the treatment group was 13.33%, obviously lower than that of 41.66% in the control group.

A Clinical observation of the therapy for malignant hydrothorax by intra-thoracic injection using IL-2 combining with Cisplatin

Objective: The aim of our study was to explore the short-term effects and complication of interleukin-2 (IL-2) combining with Cisplatin in the treatment of malignant hydrothorax.Methods: Sixty-two cases patients with malignant hydrothorax were randomly divided into two groups.Observation group was 31 examples,thoracic cavity injection IL-2 and Cisplatin;31 cases in control group using Cisplatin alone intra-thoracic injection.The regime of every week for 1–4 weeks was used to observe short term effects and complications.Results: The total response rate in observe group was higher than that in control group (90.3% vs.68.1%),which had statistically significant difference (P < 0.05).The complications included gastrointestinal tract reaction,bone marrow inhibition,chest pain and fever.The incidence rates of chest pain and fever in observe group was slightly higher than that in control group,but there was no statistically significant difference (P > 0.05).Conclusion: The IL-2 combining with Cisplatin intra-thoracic injection for malignant hydrothorax has the features of good therapeutic effects and slight poisonous side effects,which is worth to be used in clinic.

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

Objective： The aim of our study was to observe the efficacy and toxicity of 50 cases of advanced non-small cell lung cancer （NSCLC） patients treated by pemetrexed. Methods： Fifty patients, including 29 females and 21 males, with a median age 62 years （35–82 years）, 13 of whom were treated with pemetrexed only and the left 37 cases were treated with pemetrexed combined with platinum in the Department of Oncology, Renmin Hospital of Wuhan University from June 2006 to March 2009. Single agent regimen： patients received pemetrexed 500 mg/m2 on day 1 with every 21 days. Combination regimen： patients received pemetrexed 500 mg/m2 on day 1 and carboplatin 300 mg/m2 on day 1 or cisplatin 35 mg/m2 on day 1 to day 3 or nedaplatin 80 mg/m2 on day 1 by intravenous infusion with 21 days as one cycle. RECIST 1.0 standard was used to evaluate the clinical efficiency, and the WHO toxicity standard was used to evaluate toxic reaction, and the QOL was used to evaluate the quality of life. Results： All patients were given 162 cycles （at least 2 cycles, at most 6 cycles） and the response rate of all the patients were evaluated. There were 2 complete remission （CR）, 7 partial remission （PR）, 22 stable disease （SD） and 19 progressive disease （PD） in the group, the overall response rate was （RR） was 18.0% and disease control rate （DCR） 62.0%. The quality of life improvement rate reaches 58.0%. The major toxic reaction included neutropenia, thrombocytopenia, hypemia, nausea, and vomiting. Most of the severity of these effects was grade I–II and well tolerated. Conclusion： Chemotherapy with pemetrexed or pemetrexed combined with platinum in the treatment of advanced non-small cell lung cancer is effective, safe and well-tolerable, which can improve quality of life of the patient.